Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

104.06 -0.79 (-0.75%)
Official Closing Price Updated: 4:10 PM EDT, Mar 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
53 54 Next >
News headline image
$5.1 Trillion Global Surge: CEO Confidence Ignites New Era of M&A Transformation
The global Mergers and Acquisitions (M&A) market staged a historic comeback in 2025, with total deal value reaching a staggering $5.1 trillion. This resurgence represents a 44% year-over-year increase,... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗
Income investors can rely on these stocks. 
Via The Motley Fool
Topics Intellectual Property
Abbott Laboratories (NYSE:ABT) Stands Out as a Dependable Dividend Stock for Income Investors ↗
Via Chartmill
News headline image
1 Healthcare Stock to Consider Right Now and 2 We Find Risky
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and... 
Via StockStory
Topics Stocks
News headline image
The Great Diagnostic Consolidation: How a $25.7 Billion Mega-Deal Ignited a 150% Surge in Healthcare M&A
As 2026 begins, the healthcare sector is undergoing its most profound transformation in decades. Driven by a relentless push toward "precision medicine" and the industrialization of artificial... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
The Great Recalibration: Why 2026 Could Be Healthcare’s Year to Rebound
For the past two years, the U.S. healthcare sector has been the forgotten stepchild of the equity markets. As the S&P 500 (SPX) surged on the back of an artificial intelligence gold rush and a... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth
In a resounding vote of confidence for the future of multi-cancer early detection (MCED), Canaccord Genuity reiterated its "Buy" rating for GRAIL (Nasdaq: GRAL) on Tuesday, January 13, 2026, setting an... 
Via MarketMinute
News headline image
Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability
On January 12, 2026, the diagnostic sector witnessed a seismic shift as shares of Biodesix (Nasdaq: BDSX) surged more than 40% in early trading, following the release of preliminary full-year 2025... 
Via MarketMinute
Topics Artificial Intelligence Death
News headline image
Where to Invest $10,000 at the Start of This New Year ↗
It's important to diversify and focus on the long term. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Medtronic (MDT) Deep-Dive: Can the MedTech Giant Outpace the Market in 2026?
Date: January 9, 2026 Introduction As the global healthcare landscape undergoes a seismic shift toward personalized medicine and AI-integrated care, Medtronic plc (NYSE: MDT) stands at a critical... 
Via PredictStreet
Topics Artificial Intelligence Economy Product Recall
News headline image
1 S&P 500 Stock to Consider Right Now and 2 We Turn Down
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
News headline image
2 Healthcare Stocks to Buy in a Bear Market ↗
They can help you weather the storm. 
Via The Motley Fool
Topics Economy
News headline image
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
As of today, January 1, 2026, Abbott Laboratories (NYSE: ABT) stands as one of the most resilient and strategically diversified giants in the global healthcare landscape. While the broader market has... 
Via PredictStreet
Topics Economy Lawsuit World Trade
News headline image
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q3 Earnings?
Over the past six months, Abbott Laboratories’s shares (currently trading at $125.45) have posted a disappointing 7.9% loss, well below the S&P 500’s 11.2% gain. This may have investors wondering how... 
Via StockStory
Topics Stocks Supply Chain
News headline image
Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors? ↗
This basket of 64 medical device stocks could raise its dividend for decades. 
Via The Motley Fool
Topics ETFs Government Supply Chain
News headline image
Broadcom Just Raised Its Dividend—But It’s Not the Only One Signaling Strength ↗
Via MarketBeat
News headline image
2 Dividend Stocks to Buy for 2026 and Beyond ↗
The healthcare sector is a great place to find quality income stocks, and these two appear to be strong picks. 
Via The Motley Fool
News headline image
1 Safe-and-Steady Stock to Consider Right Now and 2 We Turn Down
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
Stay informed with the top movers within the S&P500 index on Monday. ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Start the New Year Off With Passive Income: 3 Dividend Kings to Buy Now ↗
These stocks will pay you just for owning them. 
Via The Motley Fool
News headline image
My Top 10 Stocks to Buy for 2026 ↗
These players are well-positioned to potentially gain next year -- and over time. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Abbott Laboratories (NYSE:ABT) Offers a Dependable Dividend Backed by Strong Fundamentals ↗
Abbott Laboratories (ABT) is a top dividend stock with a strong history of increases, backed by exceptional earnings power and a very healthy balance sheet for reliable income. 
Via Chartmill
News headline image
Danaher Sweetens the Pot: Board Approves $0.32 Quarterly Cash Dividend, Signaling Robust Financial Health
New York, NY – December 9, 2025 – Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that its Board of Directors has approved a regular quarterly cash dividend... 
Via MarketMinute
News headline image
2 Mega-Cap Stocks with Promising Prospects and 1 Facing Challenges
"Too big to fail" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their... 
Via StockStory
News headline image
Here's Why Grail Soared, Again, in November ↗
A combination of operational improvements and developments at its key rival bolstered the stock recently. 
Via The Motley Fool
News headline image
This Top Dividend King Just Became an Even Better Buy ↗
The healthcare leader wants to make waves in a potentially highly lucrative market. 
Via The Motley Fool
News headline image
Synlait Milk Trims 2025/2026 Milk Price Forecast Amidst Global Commodity Headwinds
New Zealand's Synlait Milk (NZX: SML) has announced a reduction in its annual base milk price forecast for the 2025/2026 season, signaling persistent challenges within the global dairy commodity... 
Via MarketMinute
Topics Economy Emissions Supply Chain
News headline image
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy Government World Trade
News headline image
Top 2 Healthcare Stocks Every New Investor Should Know ↗
These healthcare stocks have long-term and profitable growth runways. 
Via The Motley Fool
News headline image
2 Fantastic Dividend Stocks to Buy and Hold Forever ↗
These companies have been raising their payouts for a combined 101 consecutive years. 
Via The Motley Fool
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
53 54 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.